Literature DB >> 10607144

Consolidated and distributed nap schedules and performance.

.   

Abstract

This study compared alertness and psychomotor performance over an extended work period in which participants received either a 4-h afternoon nap or four 1-h naps during the night. It was hypothesized that alertness and performance would be superior during the night following the 4-h afternoon nap and that the overall level of performance would be related to the amount of sleep obtained. It was found that when a series of 1-h naps was taken during the normal night period, oral temperature and psychomotor performance also declined. However, performance was relatively improved on the following evening. In contrast, with an effective 4-h prophylactic nap, performance remained near baseline levels across the night. It was concluded that the placement of sleep periods during extended work be based on knowledge of when maximal performance would be required.

Entities:  

Year:  1995        PMID: 10607144     DOI: 10.1111/j.1365-2869.1995.tb00154.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  3 in total

1.  The efficacy of a restart break for recycling with optimal performance depends critically on circadian timing.

Authors:  Hans P A Van Dongen; Gregory Belenky; Bryan J Vila
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

2.  Sleep architecture of consolidated and split sleep due to the dawn (Fajr) prayer among Muslims and its impact on daytime sleepiness.

Authors:  Ahmed S Bahammam; Munir M Sharif; D Warren Spence; Seithikurippu R Pandi-Perumal
Journal:  Ann Thorac Med       Date:  2012-01       Impact factor: 2.219

Review 3.  Person-directed, non-pharmacological interventions for sleepiness at work and sleep disturbances caused by shift work.

Authors:  Tracy E Slanger; J Valérie Gross; Andreas Pinger; Peter Morfeld; Miriam Bellinger; Anna-Lena Duhme; Rosalinde Amancay Reichardt Ortega; Giovanni Costa; Tim R Driscoll; Russell G Foster; Lin Fritschi; Mikael Sallinen; Juha Liira; Thomas C Erren
Journal:  Cochrane Database Syst Rev       Date:  2016-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.